GLPs have changed consumer behavior

The rise of GLP-1 weight loss drugs is reshaping consumer behavior in ways few expected. These medications, originally developed for diabetes management, have become a dominant force in the weight loss industry, altering spending habits and disrupting major food and beverage companies. The financial fallout is already visible, with fast food chains, snack brands, and beverage giants reporting sharp declines in revenue. McDonald’s just posted its worst quarter since the pandemic, a clear sign that fewer consumers are indulging in high-calorie meals. WeightWatchers, once a staple in the diet industry, has filed for bankruptcy, unable to compete with the rapid...